Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianne C Verhaar

Showing results (1-10 of 324) with videos related to

Pageof 33
Sort By:
Current Pharmaceutical Design|June 23, 2007
Understanding eNOS for pharmacological modulation of endothelial function: a translational viewBranko Braam, Marianne C Verhaar
Nature Reviews. Nephrology|May 9, 2020
Innovations in approaches to remove uraemic toxinsRosalinde Masereeuw, Marianne C Verhaar
Tissue Engineering. Part C, Methods|February 22, 2021
Editorial for Special Issue on Drug and Disease Testing Model SystemsYing Chen, Marianne C Verhaar
Journal of Hypertension|May 15, 2010
LOX-1: luring ox-LDL into the arterial wallPeter E Westerweel, Marianne C Verhaar
PPAR Research|March 7, 2009
Protective Actions of PPAR-gamma Activation in Renal EndotheliumPeter E Westerweel, Marianne C Verhaar
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 2, 2010
Differential impact of dialysis modality on circulating endothelial progenitor cellsPeter E Westerweel, Marianne C Verhaar
Nature Reviews. Rheumatology|May 13, 2009
Endothelial progenitor cell dysfunction in rheumatic diseasePeter E Westerweel, Marianne C Verhaar
Circulation Research|September 18, 2008
Directing myogenic mesenchymal stem cell differentiationPeter E Westerweel, Marianne C Verhaar
European Journal of Pharmacology|July 5, 2016
Pluripotent stem cell-derived kidney organoids: An in vivo-like in vitro technologyFrans Schutgens, Marianne C Verhaar, Maarten B Rookmaaker
Journal of Hypertension|April 5, 2013
Bone marrow cell therapy in hypertensive kidney disease: contribution to cardiac fibrosis?Arianne van Koppen, Jaap A Joles, Marianne C Verhaar
Pageof 33

Showing results (1-10 of 324) with videos related to

Sort By:
Pageof 33
Current Pharmaceutical Design|June 23, 2007
Understanding eNOS for pharmacological modulation of endothelial function: a translational viewBranko Braam, Marianne C Verhaar
Nature Reviews. Nephrology|May 9, 2020
Innovations in approaches to remove uraemic toxinsRosalinde Masereeuw, Marianne C Verhaar
Tissue Engineering. Part C, Methods|February 22, 2021
Editorial for Special Issue on Drug and Disease Testing Model SystemsYing Chen, Marianne C Verhaar
Journal of Hypertension|May 15, 2010
LOX-1: luring ox-LDL into the arterial wallPeter E Westerweel, Marianne C Verhaar
PPAR Research|March 7, 2009
Protective Actions of PPAR-gamma Activation in Renal EndotheliumPeter E Westerweel, Marianne C Verhaar
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 2, 2010
Differential impact of dialysis modality on circulating endothelial progenitor cellsPeter E Westerweel, Marianne C Verhaar
Nature Reviews. Rheumatology|May 13, 2009
Endothelial progenitor cell dysfunction in rheumatic diseasePeter E Westerweel, Marianne C Verhaar
Circulation Research|September 18, 2008
Directing myogenic mesenchymal stem cell differentiationPeter E Westerweel, Marianne C Verhaar
European Journal of Pharmacology|July 5, 2016
Pluripotent stem cell-derived kidney organoids: An in vivo-like in vitro technologyFrans Schutgens, Marianne C Verhaar, Maarten B Rookmaaker
Journal of Hypertension|April 5, 2013
Bone marrow cell therapy in hypertensive kidney disease: contribution to cardiac fibrosis?Arianne van Koppen, Jaap A Joles, Marianne C Verhaar
Pageof 33